Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Jo Hardy
Pohutukawa-flame of the north
Lost your password? Create an account History Pohutukawa-flame of the north Whether providing shade for a summer picnic, standing sentinel on a crumbling cliff or splashing Christmas crimson along garden edge, street or shoreline, the pohutukawa is one of the trees New Zealanders hold in greatest affection. Its grizzled bark and joyous blooms speak to us not just of the enduring qualities of the tree, but of the land itself.
Epinephrine (adrenaline) compared to selective beta-2-agonist in adults or children with acute asthma: a systematic review and meta-analysis
Epinephrine (adrenaline) compared to selective beta-2-agonist in adults or children with acute asthma: a systematic review and meta-analysis http://orcid.org/0000-0002-3581-4472Christina Baggott1, http://orcid.org/0000-0002-3368-095XJo Katherine Hardy1, Jenny Sparks1, Doñah Sabbagh1, http://orcid.org/0000-0003-0337-406XRichard Beasley1,2, Mark Weatherall3, http://orcid.org/0000-0001-9148-196XJames Fingleton1,2,3 1 Medical Research Institute of New Zealand, Wellington, New Zealand 2 Capital...
Epinephrine (adrenaline) compared to selective beta-2-agonist in adults or children with acute asthma: a systematic review and meta-analysis
Epinephrine (adrenaline) compared to selective beta-2-agonist in adults or children with acute asthma: a systematic review and meta-analysis http://orcid.org/0000-0002-3581-4472Christina Baggott1, http://orcid.org/0000-0002-3368-095XJo Katherine Hardy1, Jenny Sparks1, Doñah Sabbagh1, http://orcid.org/0000-0003-0337-406XRichard Beasley1,2, Mark Weatherall3, http://orcid.org/0000-0001-9148-196XJames Fingleton1,2,3 1Medical Research Institute of New Zealand, Wellington, New Zealand 2Capital and...
Self-titration of inhaled corticosteroid and β2-agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trial
Christina Baggott, Jo Hardy, Jenny Sparks, Mark Holliday, Daniela Hall, Alexandra Vohlidkova, Robert J. Hancox, Mark Weatherall, James Fingleton, Richard Beasley on behalf of the PRACTICAL Study Team European Respiratory Journal 2020 56: 2000170; DOI: 10.1183/13993003.00170-2020 Abstract Introduction In mild asthma, as-needed budesonide–formoterol is superior or noninferior to maintenance budesonide plus as-needed short-acting β2-agonist in reducing severe exacerbations.
What matters most to patients when choosing treatment for mild-moderate asthma? Results from a discrete choice experiment
What matters most to patients when choosing treatment for mild–moderate asthma?
Self-titration of inhaled corticosteroid and beta2-agonist in response to symptoms in mild asthma - a pre-specified analysis from the PRACTICAL study, a randomised controlled trial | European Respiratory Society
Abstract Background In mild asthma, as-needed budesonide-formoterol is superior or non-inferior to maintenance budesonide plus as-needed short-acting beta2-agonist in reducing severe exacerbations. In this pre-specified analysis, we investigated patterns of inhaled corticosteroid (ICS) and beta2-agonist use in PRACTICAL, a randomised controlled trial.
Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma: findings from the PRACTICAL study, a randomised clinical trial
Christina Baggott, Helen K. Reddel, Jo Hardy, Jenny Sparks, Mark Holliday, Andrew Corin, Barney Montgomery, Jim Reid, Davitt Sheahan, Robert J.
Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma - findings from the PRACTICAL study, a randomised clinical trial | European Respiratory Society
Abstract Symptom-driven low-dose inhaled corticosteroid-formoterol is safe and effective in mild asthma and has been recommended as one of the preferred treatment regimens at steps 1 and 2 in the 2019 update of the Global Initiative for Asthma (GINA). However there are no data on patient preferences for this regimen.
Passing the baton: The importance of good handovers
Dr. Ming-Keng Teoh Head of Medical Services, Asia Medical Protection (MPS) 6 days ago Good handovers provide continuity of care and can help to avoid errors. It is common for problems to arise when a doctor is handing a patient over to another doctor for treatment – either between shifts, between phases of care, or between community and hospital care. These problems can put the patient’s safety at risk and it is therefore vital to ensure effective handovers.
Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial
Summary Background In adults with mild asthma, a combination of an inhaled corticosteroid with a fast-onset long-acting β-agonist (LABA) used as reliever monotherapy reduces severe exacerbations compared with short-acting β-agonist (SABA) reliever therapy. We investigated the efficacy of combination budesonide–formoterol reliever therapy compared with maintenance budesonide plus as-needed terbutaline.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Jo
Contact Jo, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack